CTOs on the Move


 
With iCAD`s technology, cancer has finally met its match. As a global medical technology leader providing innovative cancer detection and therapy solutions, our technologies empower clinicians worldwide with an arsenal of tools to detect cancer and stop it in its tracks – streamlining workflow, improving accuracy, and personalizing results like never before. The ProFound AI Breast Health Suite is the first, best, and only complete, triple-threat solution that combines cancer detection, density assessment, and risk evaluation – all designed to accelerate discovery and improve outcomes. Our leading-edge cancer detection solution, ProFound AI®, is clinically proven to find cancers earlier and ...
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.icadmed.com
  • 98 Spit Brook Road Suite 100
    Nashua, NH USA 03062
  • Phone: 603.882.5200

Executives

Name Title Contact Details

Funding

iCAD raised $12.5M on 04/28/2020
iCAD raised $22M on 03/03/2021

Similar Companies

HealthMedia

HealthMedia is a Ann Arbor, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Specialty Medical Supplies Inc

Specialty Medical Supplies Inc is a Pompano Beach, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Grand X-Ray Instrumentarium Imaging

Grand X-Ray Instrumentarium Imaging is a Grand Rapids, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Specific Diagnostics

Bloodstream infection leading to sepsis is responsible for more than half of all deaths in hospitals and is the most expensive condition treated in hospitals. Mortality rate increases 6% every hour from onset. Therefore, it is critical the right antibiotic treatment is determined quickly. Current methodologies require 3 days to determine the effective antibiotic. Specific Diagnostics has developed a new technology that determines the effective antibiotic in less than 1 day. Specific`s Reveal™ instrument and assay are cost effective and labor-saving allowing clinics to readily deploy the Specific Reveal solution. Specific`s unique patented technology leverages a low-cost small molecule sensor (SMS) array, enabling diagnostic products that simplify workflow and speed time-to-answer at low cost. Specific`s system streamlines lab workflow, reduce costs, and substantially shorten the time from sample arrival to selection of effective therapy, saving patients faced with fast-moving and deadly drug-resistant blood infections. Specific and its founders have written almost 60 peer-reviewed publications, detailing the successful demonstration of the SMS array technology. The Company itself has independently authored over 20 scientific publications and conference abstracts detailing the SMS array powered detection, identification and antibiotic susceptibility testing.

Scientek Technology

Scientek Technology Corp. is a Delta, BC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.